Raffi Asadorian
Chief Financial Officer, Amyris.
Companies
- AcelRx Pharmaceuticals (United States)Chief financial officer Aug 17, 2017 to now1
- AmyrisChief financial officer Jan 8, 2015 to Jan 4, 20172
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
AcelRx Pharmaceuticals (United States) TLPH85,879 shares3$93.6K at $1.09Apr 2, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 2, 2026Shares withheld for tax 2,444 shares at $0.72 of AcelRx Pharmaceuticals (United States)3
- Feb 14, 2026Shares withheld for tax 2,933 shares at $0.79 of AcelRx Pharmaceuticals (United States)4
- Feb 12, 2026Bought 45,000 shares at $0.81 of AcelRx Pharmaceuticals (United States)4
- Feb 10, 2026Shares withheld for tax 958 shares at $0.84 of AcelRx Pharmaceuticals (United States)4
- Apr 2, 2025Granted 15,000 shares of AcelRx Pharmaceuticals (United States)5
- Feb 14, 2025Shares withheld for tax 3,245 shares at $0.67 of AcelRx Pharmaceuticals (United States)6
- Feb 11, 2025Shares withheld for tax 1,060 shares at $0.62 of AcelRx Pharmaceuticals (United States)7
- Feb 10, 2025Shares withheld for tax 1,059 shares at $0.63 of AcelRx Pharmaceuticals (United States)7
- Dec 2, 2024Sold 155 shares at $0.77 of AcelRx Pharmaceuticals (United States)8
- Mar 3, 2024Shares withheld for tax 558 shares at $1.30 of AcelRx Pharmaceuticals (United States)9
- Feb 14, 2024Granted 18,000 shares of AcelRx Pharmaceuticals (United States)10
- Feb 11, 2024Shares withheld for tax 895 shares at $1.10 of AcelRx Pharmaceuticals (United States)11
- Feb 10, 2024Shares withheld for tax 895 shares at $1.10 of AcelRx Pharmaceuticals (United States)11
- Mar 3, 2023Shares withheld for tax 510 shares at $1.31 of AcelRx Pharmaceuticals (United States)12
- Feb 11, 2023Shares withheld for tax 873 shares at $1.68 of AcelRx Pharmaceuticals (United States)13
- Feb 10, 2023Granted 5,875 shares of AcelRx Pharmaceuticals (United States)13
- Feb 6, 2023Shares withheld for tax 617 shares at $2.02 of AcelRx Pharmaceuticals (United States)14
- Mar 3, 2022Shares withheld for tax 7,923 shares at $0.41 of AcelRx Pharmaceuticals (United States)15
- Feb 11, 2022Shares withheld for tax 7,927 shares at $0.40 of AcelRx Pharmaceuticals (United States)16
- Feb 11, 2022Granted 117,500 shares of AcelRx Pharmaceuticals (United States)16
- Feb 6, 2022Shares withheld for tax 9,391 shares at $0.43 of AcelRx Pharmaceuticals (United States)17
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARAmyris, Chief financial officer
- 3
- 4SEC EDGARForm 4 filed Feb 20, 2026
- 5SEC EDGARForm 4 filed Apr 3, 2025
- 6SEC EDGARForm 4 filed Feb 18, 2025
- 7SEC EDGARForm 4 filed Feb 12, 2025
- 8SEC EDGARForm 4 filed Dec 2, 2024
- 9SEC EDGARForm 4 filed Mar 4, 2024
- 10SEC EDGARForm 4 filed Feb 27, 2024
- 11SEC EDGARForm 4 filed Feb 13, 2024
- 12SEC EDGARForm 4 filed Mar 6, 2023
- 13SEC EDGARForm 4 filed Feb 14, 2023
- 14SEC EDGARForm 4 filed Feb 8, 2023
- 15SEC EDGARForm 4 filed Mar 4, 2022
- 16SEC EDGARForm 4 filed Feb 14, 2022
- 17SEC EDGARForm 4 filed Feb 7, 2022